Clinical Trials · NCT02187250
PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University Medical Centre Ljubljana
- Enrollment
- 45
- Start date
- Mar 2014
- Locations
- 1 site, Slovenia
- Primary endpoint
- The main outcome was change in body weight.